GLENMARK PHARMA (GLENMARK) - Live BSE, NSE Stock Quotes - GLENMARK PHARMA Analysis Update - Equitymaster.com
X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2015 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
McAfee Secure sites help keep you safe from identity theft, credit card fraud, spyware, spam, viruses and online scams
 
GLENMARK PHARMA   (GLPH)
REFRESH
 Live BSE Quotes Jul 3, 2015 (Close)
Price (Rs)
1,019.05
Open (Rs)
1,020.00
High (Rs)
1,033.15
Low (Rs)
1,012.10
% Change
-0.08
Volume
47,815
Value (Rs)
48,855,486
52-Week H/L
1,033.40 / 532.00

 Live NSE Quotes Jul 3, 2015 (Close)
Price (Rs)
1,019.25
Open (Rs)
1,019.40
High (Rs)
1,032.00
Low (Rs)
1,011.40
% Change
-0.02
Volume
366,409
Value (Rs)
374,021,981
52-Week H/L
1,033.70 / 530.55

 Valuation
EPS (Rs)*
24.42
P/E Ratio (x)
41.73
Market Cap (Rs m)
276,447.88
P/BV (x)
9.27
 
*Trailing 12 months earnings, excluding extraordinary / exceptional items.
BSE Sensex | CNX Nifty
GLENMARK PHARMA Stock Price Chart (Rs) - 1 Year
Loading...
  
PEER GROUP: QUOTE & GRAPH
MOVING AVERAGES 15 DMA 30 DMA 100 DMA 200 DMA
COMPARE WITH BSE-30 NSE-50 COMPANY COMPANY
VALUATION P/E Ratio P/BV COMPARE  S&P BSE SENSEX 
  PERIOD
 DO YOU LIKE OUR NEW GRAPHS? TELL US!  

Related Views On News

Cipla Limited: On a growth drive (Cool Hand Luke)

Mar 21, 2014

Luke Verghese discusses that Cipla's financials are on a roll

GSK pharma's Open offer: Our view (Company Info)

Dec 17, 2013

Should investors take advantage of the buy back offer and offload shares of GSK Pharma?

Foreign investment in pharma; walking a thin line (What We're Reading)

Oct 9, 2013

Here is today's recommended reading list from Equitymaster...

Divi's Laboratories: Cash rich operations (Cool Hand Luke)

Sep 24, 2013

Luke Verghese discusses that Divi's Laboratories is professionally managed

Sun Pharma Advanced Research: Strong R&D focus (Cool Hand Luke)

Sep 18, 2013

The Company is being very judiciously funded through permanent capital, and unsecured debt at favourable terms

More Views on News

Most Popular

Did anyone predict that these stocks would be 'Multi-losers'?(The 5 Minute Wrapup)

Jun 23, 2015

Why knowing what stocks to not invest in is as valuable as knowing which ones to expect big returns from...

The greater fool theory seems to be at work in Indian e-commerce(The Daily Reckoning)

Jun 23, 2015

Companies are driving up valuations by driving up their gross merchandise value.

Maximize Gains, Not the number of wins(Daily Profit Hunter)

Jun 27, 2015

Apurva Sheth discusses the primary objective of a trader

India to surpass China in wealth creation?(Chart Of The Day)

Jun 27, 2015

Can we see the meltdown in China’s stock markets replicated in India as well?

7 Delusions on Managing Personal Finance Busted(Mutual Fund Corner)

Jun 30, 2015

Many individuals have an erroneous perception about reality. PersonalFN has busted some delusions which people live under as they manage their personal finance.

More

TRACK GLENMARK PHARMA

  • Track your investment in GLENMARK PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON GLENMARK PHARMA

GLENMARK PHARMA 5-YR ANALYSIS

Detailed Financial Information With Charts

COMPARE GLENMARK PHARMA WITH

MARKET STATS

  1. Go